Streamlining Scale-Up and Scale-Out

Cell and Gene Therapy Symposium: Streamlining Scale-Up and Scale-Out

Now available on-demand!

Bio-Techne is hosting our next Cell and Gene Therapy Virtual Symposium.

At our last event, we discussed “The Challenges of Analyzing ATMPs” and our speakers shared solutions to overcome these challenges.

To create therapies that are accessible to all, it is key that manufacturing can be completed in a scalable and cost-effective manner. So, this time we shall be exploring the challenges and discussing possible solutions for streamlining the manufacturing process.

Join us and be part of the discussion on how we can streamline, scale-up and scale-out!

AGENDA

SCHEDULE	AGENDA
2:30 - 2:40 pm	Welcome
2:40 - 2:55 pm	David Hermansson
2:55 - 3:10 pm	Katy Newton
3:10 - 3:25 pm	Fernanda Masri
3:25 - 3:40 pm	Cathelijine van den Berg
3:40 - 4:00 pm	Roundtable
4:00 pm	Closing the session

SPEAKERS

	Jenny Stjernberg, Ph.D. Commercial Development Manager - Cell & Gene Therapy, Europe at Bio-Techne Symposium Host

	David Hermanson, PhD. Senior Manager, R&D Applications, Cell and Gene Therapy, B-MoGen “Scale-Up of Tcbuster Transposition: A Non-Viral Gene Editing Tool”

	Katy Newton, Ph.D. Vice President Process Development at Achilles Therapeutics Limited “Planning for Success - Considerations for the Design of Scalable Processes”

	Fernanda Masri, Ph.D. Solutions Manager for iPSCs – Sartorius Stedim Biotech Co-Founder and Technical Director – Yres Consulting “Practical Considerations for Large Scale Realisation of ATMPs”

	Cathelijne van den Berg, Ph.D. Assistant Professor Nephrology at LUMC and Special Adviser for NECSTGEN. “Roadmap for Clinical Grade Advanced Stem Cell Therapies for Patients with Kidney Disease”